According to GlobalData’s medical device pipeline database, seven Manganese Contrast Agents devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, five are in active development, while the remaining two are in an inactive stage of development. There are one products in the early stages of development, and the remaining four are in the late stages of development.
Manganese Contrast Agents are non-lanthanide metal manganese-based contrast agents used to increase the contrast of structures or fluids within the body in medical imaging. It can shorten the T1 of water protons and increase the signal intensity of T1w MR images. These are classified into three broad categories, i.e., small molecule agents, hybrid manganese agents (oxo clusters), and agents coupled (or incorporated into) to macromolecules or nanoparticulates.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Manganese Contrast Agents pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Manganese Contrast Agents devices. Overall, most of these Manganese Contrast Agents pipeline devices are being developed by private entities.
Key players involved in the active development of Manganese Contrast Agents include Ascelia Pharma, GE HealthCare Technologies, Massachusetts General Hospital, Massachusetts Institute of Technology, Reveal Pharmaceutical and Spago Nanomedical.
For a complete picture of the developmental pipeline for Manganese Contrast Agents devices, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.